Drug Shortage Report for JAMP ATORVASTATIN CALCIUM

Last updated on 2023-02-03 History
Report ID 180274
Drug Identification Number 02504200
Brand name JAMP ATORVASTATIN CALCIUM
Common or Proper name Atorvastatin calcium tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-12-09
Estimated end date 2023-02-10
Actual end date 2023-02-01
Shortage status Resolved
Updated date 2023-02-03
Company comments Disruption of the manufacture of the drug. Other size available.
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-01-09 English Compare
v2 2023-01-09 French Compare
v3 2023-01-10 English Compare
v4 2023-01-10 French Compare
v5 2023-02-03 English Compare
v6 2023-02-03 French Compare

Showing 1 to 6 of 6